Multinational study of pneumococcal serotypes causing acute otitis media in children

Pediatric Infectious Disease Journal

Volumn 21, Issue 11, 2002, Pages 1008-1016

  Hausdorff, William P ^a   Yothers, Greg ^b   Dagan, Ron ^c   Kilpi, Terhi ^d   Pelton, Stephen I ^e   Cohen, Robert ^f   Jacobs, Michael R ^g   Kaplan, Sheldon L ^h   Levy, Corinne ^f   Lopez, Eduardo L ⁱ   Mason Jr , Edward O ^h   Syriopoulou, Vassiliki ^j   Wynne, Brian ^k   Bryant, John ^b  

^a PFIZER INC   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e BOSTON MEDICAL CENTER   (United States)

^f ACTIV   (France)

^g CASE WESTERN RESERVE UNIVERSITY   (United States)

^h TEXAS CHILDREN S HOSPITAL   (United States)

ⁱ HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^j UNIVERSITY OF ATHENS   (Greece)

^k GLAXOSMITHKLINE   (United States)

more..

Author keywords

Acute otitis media; Pneumococcus; Serotypes

Indexed keywords

PENICILLIN G; PNEUMOCOCCUS VACCINE;

AGE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; CULTURE MEDIUM; DEMOGRAPHY; GEOGRAPHIC INFORMATION SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MIDDLE EAR EFFUSION; NONHUMAN; OTITIS MEDIA; PRIORITY JOURNAL; SEROTYPE; SEX ROLE; STREPTOCOCCUS PNEUMONIAE;

AGE FACTORS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; OTITIS MEDIA; PENICILLIN RESISTANCE; PENICILLINS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 0036846809     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200211000-00007     Document Type: Article

References (33)

1. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997; 46:1-24.
2. Giebink GS. The prevention of pneumococcal disease in children. N Engl J Med 2001;345:1177-83.
3. Hausdorff WP, Bryant J, Paradiso PR, Siber GR. Which pneumococcal serogroups cause the most invasive disease: Implications for conjugate vaccine formulation and use: Part I. Clin Infect Dis 2000;30:100-21.
4. Hausdorff WP, Bryant J, Kloek C, Paradiso PR, Siber GR. The contribution of specific pneumococcal serogroups to different disease manifestations: Implications for conjugate vaccine formulation and use: Part II. Clin Infect Dis 2000;30: 122-40.
5. Wald ER, Mason EO, Bradley JS, Barson WJ, Kaplan SL, Group USPMPS. Acute otitis media caused by Streptococcus pneumoniae in children's hospitals between 1994 and 1997. Pediatr Infect Dis J 2001;20:34-9.
6. Joloba ML, Windau A, Bajaksouzian S, Appelbaum PC, Hausdorff WP, Jacobs MR. Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media. Clin Infect Dis 2001;33:1489-4.
7. Dagan R, Givon-Lavi N, Shkolnik L, Yagupsky P, Fraser D. Acute otitis media caused by antibiotic-resistant Streptococcus pneumoniae in Southern Israel: Implication for immunizing with conjugate vaccines. J Infect Dis 2000;181:1322-9.
8. Austrian R, Howie VM, Ploussard JH. The bacteriology of pneumococcal otitis media. Johns Hopkins Med J 1977;141: 104-11.
9. Kamme C, Ageberg M, Lundgren K. Distribution of Diplococcus pneumoniae types in acute otitis media in children and the influence of the types on the clinical course in penicillin V therapy. Scand J Infect Dis 1970;2:183-90.
10. Orange M, Gray BM. Pneumococcal serotypes causing disease in children in Alabama. Pediatr Infect Dis J 1993;12: 244-5.
11. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Eng J Med 2001;344:403-9.
12. Kilpi T, Herva E, Kaijalainen T, Syrjanen R, Takala AK. Efficacy of a seven-valent pneumococcal conjugate vaccine (PncOMPC) against serotype-specific acute otitis media (AOM) caused by Streptococcus pneumoniae (Pnc) [Abstract 689]. In: 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, September 17 to 20, 2000. Washington, DC: American Society for Microbiology, 2000:245.
13. Jacobs MR, Dagan R, Appelbaum PC, Burch DJ. Prevalence of antimicrobial-resistant pathogens in middle ear fluid: Multinational study of 917 children with acute otitis media. Antimicrob Agents Chemother 1998;42:589-95.
14. Kilpi T, Herva E, Kaijalainen T, Syrjanen R, Takala AK. Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life. Pediatr Infect Dis J 2001;20:654-62.
15. Goldblatt EL, Dohar J, Nozza RJ, et al. Topical ofloxacin vs. systemic amoxicillin/clavulanate in purulent otorrhea in children with tympanostomy tubes. Int J Pediatr Otorhinolaryngol 1998;46:91-101.
16. Dohar J, Garner E, Nielsen R, Biel M, Seidlin M. Topical ofloxacin treatment of otorrhea in children with tympanostomy tubes. Arch Otolaryngol Head Neck Surg 1999;125:537-45.
17. Daly KA, Giebink GS. Clinical epidemiology of otitis media. Pediatr Infect Dis J 2000;19:S31-6.
18. Robbins JB, Austrian R, Lee CJ, et al. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis 1983;148:1136-59.
19. Eskola J. Polysaccharide-based pneumococcal vaccines in the prevention of acute otitis media. Vaccine 2001;19:S78-82.
20. Verhaegen J, Ven JVD, Verbiest N, Eldere JV, Verbist L. Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Belgium: Update(1994-98). Clin Microbiol Infect 2000;6:308-15.
21. Sih TM. Acute otitis media in brazilian children: Analysis of microbiology and antimicrobial susceptibility. Ann Otol Rhinol Laryngol 2001;110:662-6.
22. Jacobs MR, Bajaksouzian S, Zilles A, Lin G, Pankuch GA, Appelbaum PC. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 US surveillance study. Antimicrob Agents Chemother 1999;43:1901-8.
23. Fenoll A, Jado I, Viciso D, Perez A, Casal J. Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: Update (1990 to 1996). J Clin Microbiol 1998;36: 3447-54.
24. Hausdorff WP, Siber G, Paradiso PR. Geographic differences in invasive pneumococcal disease rates and serotype frequency in young children. Lancet 2001;357:950-2.
25. Di Fabio JL, Castaneda E, Agudelo CI, et al. Evolution of Streptococcus pneumoniae serotypes and penicillin susceptibility in Latin America, Sireva-Vigia Group 1993-1999. Pediatr Infect Dis J 2001;20:959-67.
26. Kaltoft MS, Zuethen N, Konradsen HB. Epidemiology of invasive pneumococcal infections in children aged 0-6 years in Denmark: A 19-year nationwide surveillance study. Acta Paediatr Suppl 2000;435:3-10.
27. Miller E, Waight P, Efstratiou A, Brisson M, Johnson A, George R. Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996-1998. Acta Paediatr Suppl 2000;435:11-16.
28. Becken ET, Daly KA, Lindgren BR, Meland MH, Giebink GS. Low cord blood pneumococcal antibody concentrations predict more episodes of otitis media. Arch Otolaryngol Head Neck Surg 2001;127:517-22.
29. Faden H, Duffy L, Wasielewski R, et al. Relationship between nasopharyngeal colonization and the development of otitis media in children. J Infect Dis 1997;175:1440-5.
30. Koskela M, Leinonen M, Haiva VM, Timonen M, Makela PH. First and second dose antibody responses to pneumococcal polysaccharide vaccine in infants. Pediatr Infect Dis 1986;5: 45-50.
31. Soininen A, Pursiainen H, Kilpi THK. Natural development of antibodies to pneumococcal capsular polysaccharides depends on the serotype: Association with pneumococcal carriage and acute otitis media in young children. J Infect Dis 2001;184:569-76.
32. Kaplan SL, Mason EO Jr, Wald ER, et al. Pneumococcal mastoiditis in children. Pediatrics 2000;106:695-9.
33. Scott JAG, Hall AJ, Dagan R, et al. Serogroup-specific epidemiology of Streptococcus pneumoniae: Associations with age, sex and geography in 7000 episodes of invasive disease. Clin Infect Dis 1996;22:973-81.